Comparison of Oral and Inhalation Exposures to Toluene

Abstract

Male Fisher-344 rats were exposed to [¹⁴C]toluene by either liquid gavage or vapor inhalation and blood toluene levels were measured by radiospectroscopy. Oral doses of 110, 336, 741, and 911 mg toluene/kg body weight were administered to 82 rats by gavage and blood toluene levels were followed for 6 h. For the inhalation group (120 rats), 3-h exposures to 99, 549, and 1,145 ppm were given and blood toluene levels were measured during this 3-h uptake phase and during a 4-h elimination period. The data for these two exposure methods were fitted to parametric kinetic models, and the resulting curves were then integrated. The blood toluene versus time profiles for oral and inhalation exposures were then compared and the equation: In(oral dosage, mg/kg) = -1.44 + 0.95 In(3-h inhalation exposure concentration, ppm) was derived (where In represents the natural logarithm). This equation describes the relation between toluene inhalation and oral exposure methods used in this study. This investigation demonstrates that oral toluene administration produces high blood toluene concentrations that can simulate the blood levels achieved after inhalation exposure to this solvent.

Keywords

Toluene Oral exposure Inhalation exposure Rat Radiospectroscopy

References

Benignus VA . Health effects of toluene: a review. Neurotoxicology 1981;2:567–88.

Benignus VA , Muller KE , Barton CN , Bittikofer JA . Toluene levels in blood and brain of rats during and after respiratory exposure. Toxicol Appl Pharmacol 1981;61:326–34.

Bruckner JV , Peterson RG . Evaluation of toluene and acetone inhalant abuse. I. Pharmacokinetics and pharmacodynamics. Toxicol Appl Pharmacol 1981;61:27–38.

Gospe SM , Calaban MJ . Central nervous system distribution of inhaled toluene. Fund Appl Toxicol 1988;11:540–5.

Gospe SM , Saeed DB , Zeman FJ . Development of an animal model of toluene embryopathy (fetal solvents syndrome). Pediatr Res 1991;29:69A.

Hersh JH , Podruch PE , Rogers G , Weisskopf B . Toluene embryopathy. J Pediatrics 1985;106:922–7.

Knaak JB , Al-Bayati MA , Raabe OG , Blancato JN . In vivo percutaneous absorption studies in the rat: pharmacokinetics and modeling of isofenphos absorption. In: Scott RC , Guy RH , Hadgraft J , eds. Prediction of percutaneous penetration: methods, measurements, and modelling. London: IBC Technical, 1990:2–18.

Low LK , Meeks JR , Mackerer CR . Health effects of the alkyl benzenes. I. Toluene. Toxicol Ind Health 1988;4:49–75.

Pyykko K , Tahiti H , Vapaatalo H . Toluene concentration in various tissues of rats after inhalation and oral administration. Arch Toxicol 1977;38:169–76.

10.

Raabe OG. Retention and metabolism of toxics: inhalation uptake of xenobiotic vapors by people. Report submitted to California Air Resources Board, Sacramento (CARB Contract No. A5-155-33).

11.

Raabe OG , Al-Bayati MA , Teague SV , Rasolt A . Regional deposition of inhaled monodisperse, coarse, and fine aerosol particles in small laboratory animals. Ann Occup Hyg 1988;32(Suppl 1):53–63.

12.

Rosenberg NL , Kleinschmide-DeMasters BK , Davis KA , et al. Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol 1988;23:611–4.

13.

Sullivan MJ , Conolly RB . Comparison of blood toluene levels after inhalation and oral administration. Environm Res 1988;45:64–70.